Zawel Leigh
SEC CIK 1837456 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | See Remarks | 69.8K | — | $4.65M | 9 | 2021-08-09 | 2022-02-11 |
Most active insiders at CGEM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 10% | $11.93M | — |
| 2 | Michaelson Jennifer | CSO | — | $1.62M |
| 3 | Nichols Weston | 10% | $1.39M | — |
| 4 | AHMED NADIM | Pres, CEO, Dir | — | $518.0K |
| 5 | Jones Jeffrey Alan | Chief Medical Off | — | $178.9K |
| 6 | SUMER JACQUELYN L | CLO | — | $136.7K |
| 7 | Fenton Mary Kay | CFO | — | $59.9K |
Zawel Leigh made no open-market trades at CGEM in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-15 | 2022-02-11 | CGEM | Cullinan Therapeutics, Inc. | Zawel Leigh | See Remarks | A - Grant | $0.00 | +32.5K | 69.8K | +87% | $0 |
| 2021-10-18 | 2021-10-15 | CGEM | Cullinan Therapeutics, Inc. | Zawel Leigh | See Remarks | S - Sale | $25.00 | -19.6K | 37.3K | -34% | -$489.4K | |
| 2021-10-12 | 2021-10-07 | CGEM | Cullinan Therapeutics, Inc. | Zawel Leigh | See Remarks | S - Sale | $25.00 | -1,079 | 56.9K | -2% | -$27.0K | |
| 2021-09-21 | 2021-09-20 | CGEM | Cullinan Therapeutics, Inc. | Zawel Leigh | See Remarks | S - Sale | $25.16 | -7,468 | 57.9K | -11% | -$187.9K | |
| 2021-09-08 | 2021-09-07 | CGEM | Cullinan Therapeutics, Inc. | Zawel Leigh | See Remarks | S - Sale | $28.95 | -28.1K | 65.4K | -30% | -$814.0K | |
| A | 2021-08-26 | 2021-08-23 | CGEM | Cullinan Therapeutics, Inc. | Zawel Leigh | See Remarks | S - Sale | $29.00 | -28.1K | 93.5K | -23% | -$815.4K |
| MA | 2021-08-26 | 2021-08-09+ | CGEM | Cullinan Therapeutics, Inc. | Zawel Leigh | See Remarks | S - Sale | $26.77 | -28.1K | 130.3K | -18% | -$752.9K |
| 2021-08-24 | 2021-08-23 | CGEM | Cullinan Therapeutics, Inc. | Zawel Leigh | See Remarks | S - Sale | $29.00 | -28.1K | 93.5K | -23% | -$815.4K | |
| M | 2021-08-11 | 2021-08-09+ | CGEM | Cullinan Therapeutics, Inc. | Zawel Leigh | See Remarks | S - Sale | $26.77 | -28.1K | 123.5K | -19% | -$752.9K |
Purchase Sale Sale after option exercise All abbreviations